• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Obstetrics

LARC use associated with a lesser likelihood of condom use in teenage girls

byMaren ShapiroandLeah Hawkins Bressler, MD, MPH
March 20, 2016
in Obstetrics, Pediatrics
Reading Time: 3 mins read
Lower long-term IUD use among young women
Share on FacebookShare on TwitterShare on LinkedIn

1. High school girls using intrauterine devices (IUDs) or implants were less likely to use condoms than girls who used birth control pills.

2. Key findings suggest that long acting reversible contraception (LARC) users may be at increased risk for sexually transmitted diseases compared to pill users.

Evidence Rating Level: 2 (Good)

Study Rundown: Teen pregnancy rates in the United States remain some of the highest of any industrialized country. To battle this public health epidemic, The American College of Obstetrics and Gynecology (ACOG) recommends LARCs, like IUDs and implants, as first-line birth control for all women, including teenagers. LARCs are user independent, or “forgettable,” and are by far the most effective form of contraception available, with failure rates of less than 1 percent. Comparatively, birth control pills have nearly a 10 percent failure rate with typical use. However, LARCs do not protect against sexually transmitted infections (STIs). Some experts fear that given how effective LARCs are, teens won’t use both methods. In fact, several recent studies have suggested as such. In this study, researchers expanded this evidence base by comparing condom use between LARC and moderately effective contraceptive users in a nationally representative sample of US high school students.

Findings demonstrate that high school girls who used IUDs and implants were less likely to additionally use condoms than girls who used birth control pills. LARC users were also more than two times more likely to have had two or more recent sexual partners. While the cohort was nationally representative, it was fairly racially homogenous—nearly 60 percent of students were white. Future investigations might also assess potential confounders like relationship status, STI status, latex allergy, and other reasons teens may not use condoms to better understand how providers can improve counseling and management to increase adherence to safe sex practices.

Click to read the study in JAMA Pediatrics

RELATED REPORTS

Teen pregnancy associated with increased risk of premature mortality in Canada

Religious affiliation may influence the type of contraception used by women in the postpartum period

Click to read the accompanying editorial

Relevant Reading: Youth Risk Behavior Surveillance–United States, 2013

In-Depth [cross-sectional study]: Data on sexually active female students (n = 2288) was abstracted from the 2013 national Youth Risk Behavior Survey, which queried a nationally representative sample of US high school students. The primary outcome was contraceptive method used at last sexual intercourse, for which respondents could select birth control pills (22.4%), condoms (40.8%), a LARC method (IUD or implant) (1.8%), injection/patch/ring (5.7%), withdrawal/other (11.8%), not sure (1.9%), and/or none (15.7%). A secondary outcome, assessed by a separate question, was condom use at last sexual intercourse.

Compared to pill users, LARC users were less likely to use condoms (adjusted prevalence ratio [aPR]: 0.42; 95%CI: 0.21-0.84). LARC users were more likely to have had 2 or more recent sexual partners than pill users (aPR: 2.61; 95%CI: 0.21-0.84) or injection/patch/ring users (aPR: 2.58; 95%CI: 1.17-5.67). There was no significant difference in condom use seen between LARC users and injection/patch/ring users.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: intrauterine device (IUD)long-acting reversible contraception (LARC)teen pregnancy
Previous Post

Concussions associated with an increased risk of subsequent suicide

Next Post

Silicon microparticles may improve chemotherapeutic delivery to metastatic tumors in mice [PreClinical]

RelatedReports

Chronic Disease

Teen pregnancy associated with increased risk of premature mortality in Canada

March 23, 2024
Obstetrics

Religious affiliation may influence the type of contraception used by women in the postpartum period

April 24, 2023
Lower long-term IUD use among young women
Obstetrics

No difference in complete expulsion of intrauterine device between early and standard interval postpartum placement

June 1, 2023
Contraception collage: a T-shaped IUD, a round blister pack of pills and an hourglass, looped by a teal ribbon
Emergency

Postpartum patients may be at an increased risk of intrauterine device-related perforation

June 15, 2022
Next Post

Silicon microparticles may improve chemotherapeutic delivery to metastatic tumors in mice [PreClinical]

Pessary side effects not improved with lubricant

Cervical pessary does not lower rate of preterm delivery

No long-term outcome differences between stenting versus surgery for carotid stenosis

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Medicaid status, race and ethnicity are independently associated with increased odds of severe maternal morbidity
  • Artificial intelligence-generated pre-visit summaries improved communication outcomes in neurosurgical consultations
  • Midline catheters may reduce catheter-related bloodstream infections compared with peripherally inserted central catheters in intensive care unit patients
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.